Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 8Breast Neoplasms 7Polycythemia Vera 5Venous Thromboembolism 3Melanoma 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Tobacco Use Disorder 2Thrombocythemia, Essential 2Smoking Cessation 2Rectal Neoplasms 2Prostatic Neoplasms 2Neoplastic Cells, Circulating 2Neoplasms 2Neoplasm Metastasis 2Myeloproliferative Disorders 2Multiple Myeloma 2Lung Neoplasms 2Barrett Esophagus 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Tuberous Sclerosis 1Thromboembolism 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Seizures 1Salivary Gland Neoplasms 1Recurrence 1Primary Myelofibrosis 1Precancerous Conditions 1

Interventions

tislelizumab 1Tomography, X-Ray Computed 1Tomography 1Positron-Emission Tomography 1Positron Emission Tomography Computed Tomography 1Limonene 1Fluorodeoxyglucose F18 1Diagnostic Imaging 1Aspirin 14-(3-fluoropropyl)glutamic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Multiple Pulmonary Nodules × Aspirin × Clear all
NCT02169271 2020-05-21

Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules

National Cancer Institute (NCI)

Phase 2 Completed
109 enrolled 27 charts

Tobacco Use Disorder, Smoking Cessation, Multiple Pulmonary Nodules

Data powered by HemOnc (CC BY 4.0) Colophon âš¡